Skip to article
HealthLine
Emergent Story mode

Now reading

Overview

1 / 13 2 min 5 sources Multi-Source
Sources

Story mode

HealthLineMulti-SourceSource gap: Single-outlet source gap7 sections

Supreme Court rules against Colorado ban on ‘conversion therapy’ for LGBTQ kids

The Supreme Court ruled against a Colorado law banning "conversion therapy" for LGBTQ+ kids, while major pharmaceutical companies like Eli Lilly made significant deals, and health tech companies like Whoop secured substantial investments.

Read
2 min
Sources
5 sources
Domains
1
Sections
7

The Supreme Court ruled against a Colorado law banning "conversion therapy" for LGBTQ+ kids, while major pharmaceutical companies like Eli Lilly made significant deals, and health tech companies like Whoop secured...

Story state
Deep multi-angle story
Evidence
What Happened
Coverage
7 reporting sections
Next focus
What Comes Next

Story step 1

Multi-SourceSource gap: Single-outlet source gap

What Happened

The Supreme Court ruled against a Colorado law banning "conversion therapy" for LGBTQ+ kids, one of about two dozen states that ban the discredited...

Step
1 / 7
  • The Supreme Court ruled against a Colorado law banning "conversion therapy" for LGBTQ+ kids, one of about two dozen states that ban the discredited practice.
  • Eli Lilly is buying Centessa Pharmaceuticals in a deal worth at least $6.3 billion, picking up a promising narcolepsy treatment.
  • Whoop, the maker of health and fitness tracking wristbands, raised $575 million from investors, valuing the company at $10 billion.
  • OpenEvidence inked a deal with a major health system, expanding its reach in the health tech space.

Continue in the field

Focused storyNearby context

Open the live map from this story.

Carry this article into the map as a focused origin point, then widen into nearby reporting.

Leave the article stream and continue in live map mode with this story pinned as your origin point.

  • Open the map already centered on this story.
  • See what nearby reporting is clustering around the same geography.
  • Jump back to the article whenever you want the original thread.
Open live map mode

Story step 2

Multi-SourceSource gap: Single-outlet source gap

Why It Matters

The Supreme Court's ruling on "conversion therapy" has significant implications for LGBTQ+ rights, while the pharmaceutical deals highlight the...

Step
2 / 7

The Supreme Court's ruling on "conversion therapy" has significant implications for LGBTQ+ rights, while the pharmaceutical deals highlight the industry's ongoing efforts to adapt to changing market conditions. The investments in health tech companies like Whoop demonstrate the growing interest in digital health solutions.

Story step 3

Multi-SourceSource gap: Single-outlet source gap

What Experts Say

The Supreme Court's ruling is a setback for LGBTQ+ rights, but we will continue to fight for the rights of our community." — LGBTQ+ rights advocate

Step
3 / 7
"The Supreme Court's ruling is a setback for LGBTQ+ rights, but we will continue to fight for the rights of our community." — LGBTQ+ rights advocate

Story step 4

Multi-SourceSource gap: Single-outlet source gap

Key Numbers

$6.3 billion: The value of Eli Lilly's deal to buy Centessa Pharmaceuticals 24: The number of states that ban "conversion therapy" for LGBTQ+ kids

Step
4 / 7
  • $6.3 billion: The value of Eli Lilly's deal to buy Centessa Pharmaceuticals
  • 24: The number of states that ban "conversion therapy" for LGBTQ+ kids

Story step 5

Multi-SourceSource gap: Single-outlet source gap

Key Facts

Step
5 / 7

Story step 6

Multi-SourceSource gap: Single-outlet source gap

Key Facts

What: Supreme Court ruling on "conversion therapy" ban Where: Colorado Impact: Significant implications for LGBTQ+ rights Who: Eli Lilly, Centessa...

Step
6 / 7
  • What: Supreme Court ruling on "conversion therapy" ban
  • Where: Colorado
  • Impact: Significant implications for LGBTQ+ rights
  • Who: Eli Lilly, Centessa Pharmaceuticals, Whoop
  • What: Major deals and investments in pharma and health tech

Story step 7

Multi-SourceSource gap: Single-outlet source gap

What Comes Next

The Supreme Court's ruling on "conversion therapy" is likely to face ongoing challenges, while the pharmaceutical industry will continue to adapt to...

Step
7 / 7

The Supreme Court's ruling on "conversion therapy" is likely to face ongoing challenges, while the pharmaceutical industry will continue to adapt to changing market conditions. The growth of health tech companies like Whoop is expected to continue, driven by increasing demand for digital health solutions.

Cited sources

Source gap: Single-outlet source gap

Multi-Source

5 cited references across 1 linked domains.

References
5
Domains
1

5 cited references across 1 linked domain. Source gap watch: Single-outlet source gap.

  1. Source 1 · Fulqrum Sources

    Supreme Court rules against Colorado ban on ‘conversion therapy’ for LGBTQ kids

  2. Source 2 · Fulqrum Sources

    STAT+: OpenEvidence inks deal with major health system

  3. Source 3 · Fulqrum Sources

    STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more

  4. Source 4 · Fulqrum Sources

    STAT+: Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal

Open source path

For sponsors

HealthLineSource gap watch

Reach readers following this story path.

Reach readers choosing HealthLine coverage with 5 cited references and a clear next-step path.

Evidence
5
Read
2 min

Package the article, desk, and newsletter path around readers already choosing this context.

Sponsor this context

Keep reporting

ContradictionsEvent arcNarrative drift

Open the deeper source boards.

Take the mobile reel into contradictions, event arcs, narrative drift, and the full source workspace.

  • Scan the cited sources and coverage list first.
  • Keep a source-gap watch on Single-outlet source gap.
  • Revisit the core evidence in What Happened.
Open source boards

Stay in the reporting trail

Open the source boards, cited outlets, and related analysis.

Jump from the app-style read into the deeper source path without losing your place in the story.

Open source pathBack to HealthLine
⚕️ HealthLine

Supreme Court rules against Colorado ban on ‘conversion therapy’ for LGBTQ kids

The Supreme Court ruled against a Colorado law banning "conversion therapy" for LGBTQ+ kids, while major pharmaceutical companies like Eli Lilly made significant deals, and health tech companies like Whoop secured substantial investments.

By Emergent News Desk

Tuesday, July 14, 2026 • 2 min read • 5 source references

  • 2 min read
  • 5 source references

The Supreme Court ruled against a Colorado law banning "conversion therapy" for LGBTQ+ kids, while major pharmaceutical companies like Eli Lilly made significant deals, and health tech companies like Whoop secured substantial investments.

Story pulse
Story state
Deep multi-angle story
Evidence
What Happened
Coverage
7 reporting sections
Next focus
What Comes Next

What Happened

  • The Supreme Court ruled against a Colorado law banning "conversion therapy" for LGBTQ+ kids, one of about two dozen states that ban the discredited practice.
  • Eli Lilly is buying Centessa Pharmaceuticals in a deal worth at least $6.3 billion, picking up a promising narcolepsy treatment.
  • Whoop, the maker of health and fitness tracking wristbands, raised $575 million from investors, valuing the company at $10 billion.
  • OpenEvidence inked a deal with a major health system, expanding its reach in the health tech space.

Advertisement

Ad slot: in-article

Why It Matters

The Supreme Court's ruling on "conversion therapy" has significant implications for LGBTQ+ rights, while the pharmaceutical deals highlight the industry's ongoing efforts to adapt to changing market conditions. The investments in health tech companies like Whoop demonstrate the growing interest in digital health solutions.

What Experts Say

"The Supreme Court's ruling is a setback for LGBTQ+ rights, but we will continue to fight for the rights of our community." — LGBTQ+ rights advocate

Key Numbers

  • $6.3 billion: The value of Eli Lilly's deal to buy Centessa Pharmaceuticals
  • 24: The number of states that ban "conversion therapy" for LGBTQ+ kids

Key Facts

Key Facts

  • What: Supreme Court ruling on "conversion therapy" ban
  • Where: Colorado
  • Impact: Significant implications for LGBTQ+ rights
  • Who: Eli Lilly, Centessa Pharmaceuticals, Whoop
  • What: Major deals and investments in pharma and health tech

What Comes Next

The Supreme Court's ruling on "conversion therapy" is likely to face ongoing challenges, while the pharmaceutical industry will continue to adapt to changing market conditions. The growth of health tech companies like Whoop is expected to continue, driven by increasing demand for digital health solutions.

Coverage tools

Sources, context, and related analysis

Source path

How this briefing, its cited outlets, and the next reporting move fit together

A compact source board that keeps the article legible while showing what supports the current read and what would most improve the coverage next.

Cited sources

0

Reading points

3

Source links

2

Next checks

1

Source map

From briefing to cited outlets to next reporting move

Source path ready

Story geography

Where this reporting sits on the map

Use the map-native view to understand what is happening near this story and what adjacent reporting is clustering around the same geography.

Geo context
0.00° N · 0.00° E Mapped story

This story is geotagged. Nearby related reporting is not ready yet, so the live map is the best next context check.

Continue in live map mode

Coverage at a Glance

5 sources

Compare coverage, inspect perspective spread, and open primary references side by side.

Linked Sources

5

Distinct Outlets

1

Viewpoint Center

Not enough mapped outlets

Outlet Diversity

Very Narrow
0 sources with viewpoint mapping 0 higher-credibility sources
Coverage is still narrow. Treat this as an early map and cross-check additional primary reporting.

Coverage Gaps to Watch

  • Single-outlet dependency

    Coverage currently traces back to one domain. Add independent outlets before drawing firm conclusions.

  • Thin mapped perspectives

    Most sources do not have mapped perspective data yet, so viewpoint spread is still uncertain.

  • No high-credibility anchors

    No source in this set reaches the high-credibility threshold. Cross-check with stronger primary reporting.

Read Across More Angles

Check the live source-balance watch

Frontier can tell you whether this story’s lane has too few sources, one dominant format, or missing stronger anchors right now.

Open frontier →

Audit how this story fits your mix

Reader Lens now tracks source-dossier and lane visits, so you can see whether this story expands your overall reading behavior or reinforces a rut.

Open Reader Lens →

Source-by-Source View

Search by outlet or domain, then filter by credibility, viewpoint mapping, or the most-cited lane.

Showing 5 of 5 cited sources with links.

Unmapped Perspective (5)

statnews.com

Supreme Court rules against Colorado ban on ‘conversion therapy’ for LGBTQ kids

Open

statnews.com

Unmapped bias Credibility unknown Dossier
statnews.com

STAT+: OpenEvidence inks deal with major health system

Open

statnews.com

Unmapped bias Credibility unknown Dossier
statnews.com

STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more

Open

statnews.com

Unmapped bias Credibility unknown Dossier
statnews.com

STAT+: Whoop, maker of health and fitness tracking wristbands, valued at $10 billion after latest fundraising

Open

statnews.com

Unmapped bias Credibility unknown Dossier
statnews.com

STAT+: Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal

Open

statnews.com

Unmapped bias Credibility unknown Dossier
Source-linked Fast briefing Contrast-aware

Emergent News uses automated assistance to gather, compare, and summarize coverage from 5 cited sources. Review the source list below before relying on the story.